Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
World Neurosurg. 2013 Mar-Apr;79(3-4):551-7. doi: 10.1016/j.wneu.2011.09.022. Epub 2011 Nov 1.
Postoperative cerebrospinal fluid (CSF) leak in neurosurgery remains a significant source of morbidity. TissuePatchDural (TPD), a novel impermeable adhesive membrane, can be used to reinforce dural closure in cases considered at high risk to develop postoperative CSF leak.
A retrospective, single-center, clinical investigation was conducted on 119 patients who underwent elective neurosurgical procedures between January and June 2010. Inclusion criteria included adult patients undergoing clean elective surgeries where a primary watertight closure was not possible. Three groups of patients were considered: 1) infratentorial, 67 cases; 2) supratentorial, 34 cases; and 3) spinal, 18 cases. All these patients received TPD to reinforce dural closure. Preoperative (long-term corticosteroid therapy, previous surgery and radiotherapy), intraoperative (site of procedures and size of dural gap), and postoperative (early and late hydrocephalus) conditions were analyzed as possible risk factors associated with CSF leakage.
The mean follow-up was 7.14 months (range 6-12 months). CSF leak was detected in 11 of 119 cases (9.2%). The presence of pre- and postoperative risk factors was associated with a higher percentage of CSF leakage: 8 of 22 cases (36.3%) vs. 3 of 97 cases (3.1%) (P < 0.0001). All leaks could be conservatively treated and no patient required readmission or second surgery. No TPD-related adverse or allergic effects were observed.
TPD seems to be a safe tool to be used to reinforce dural closure in patients with a high risk of developing CSF leaks.
神经外科术后脑脊液(CSF)漏仍然是发病率的一个重要来源。TissuePatchDural(TPD)是一种新型的不可渗透的粘合剂膜,可用于强化被认为有发生术后 CSF 漏高风险的硬脑膜闭合。
对 2010 年 1 月至 6 月期间接受择期神经外科手术的 119 例患者进行了回顾性、单中心、临床研究。纳入标准包括接受清洁择期手术且无法进行原发性防水硬脑膜闭合的成年患者。考虑了三组患者:1)后颅窝,67 例;2)幕上,34 例;3)脊柱,18 例。所有这些患者均接受 TPD 强化硬脑膜闭合。分析了术前(长期皮质类固醇治疗、既往手术和放疗)、术中(手术部位和硬脑膜间隙大小)和术后(早期和晚期脑积水)的情况,以确定与 CSF 漏相关的可能危险因素。
平均随访时间为 7.14 个月(6-12 个月)。119 例患者中有 11 例(9.2%)出现 CSF 漏。术前和术后危险因素的存在与 CSF 漏的发生率较高相关:22 例中有 8 例(36.3%),97 例中有 3 例(3.1%)(P<0.0001)。所有漏液均可保守治疗,无患者需要再次入院或再次手术。未观察到与 TPD 相关的不良反应或过敏反应。
TPD 似乎是一种安全的工具,可用于强化有发生 CSF 漏高风险的患者的硬脑膜闭合。